Company Announcements
Director/PDMR Shareholding
Related Companies
By LSE RNS
3 October 2017
RECKITT BENCKISER GROUP PLC
DIRECTOR/PDMR SHAREHOLDINGS
Notification of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
The Company received notification today, that on 29 September 2017, the following Directors/PDMRs acquired shares through participation in the Company's Dividend Reinvestment Plan:
|
Name |
Director / PDMR |
Number of Shares Acquired |
Price per Share |
Total Holding following notification |
Percentage of Issued Share Capital (excluding treasury shares) |
|
Mary Harris |
Director |
18 |
£67.78 |
1,902 |
0.00027% |
|
Rob De Groot |
PDMR |
311 |
£67.78 |
330,316 |
0.04694% |
|
Roberto Funari |
PDMR |
434 |
£67.78 |
156,640 |
0.02226% |
The following notifications are made in accordance with the requirements of the EU Market Abuse Regulation.
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Mary Harris |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Director |
||||
|
b) |
Initial notification/ |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Reckitt Benckiser Group plc |
||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
||||
|
b) |
Nature of the transaction |
Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
|
e) |
Date of the transaction |
2017-09-29 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Rob De Groot |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR - Area EVP, ENA |
||||
|
b) |
Initial notification/ |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Reckitt Benckiser Group plc |
||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
||||
|
b) |
Nature of the transaction |
Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
|
e) |
Date of the transaction |
2017-09-29 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Roberto Funari |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR - EVP, Category Development Organisation |
||||
|
b) |
Initial notification/ |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Reckitt Benckiser Group plc |
||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
||||
|
b) |
Nature of the transaction |
Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||
|
e) |
Date of the transaction |
2017-09-29 |
||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
||||
For further Information:
Christine Logan
Deputy Company Secretary
Tel +44 (0) 1753 217 800
About RB:
RB* is the global leading consumer health and hygiene company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.
RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, French's, Calgon, Woolite and Air Wick.
RB's unique culture is at the heart of its success. Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide. RB is proud to lead the Save a Child a Minute campaign, which aims to eliminate child deaths from diarrhoea, one of the world's largest killers of children under five.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of companies
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN